Collectively, KDM5B could activate the YTHDF3/ITGA6 pathway to enhance the proliferation and growth of tumour cells by inhibiting the expression of miR‐448 in HCC, eventually leading to the occurrence of HCC. Here, YTHDF3 is linked to hepatocellular carcinoma.